EU filing for GSK’s shingles jab
GlaxoSmithKline has submitted its experimental shingles vaccines to European regulators, seeking approval to market its use to prevent herpes zoster (shingles) in people aged 50 years or over.
Read More
Tag: PHN
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
